Skip to content

In vivo inhibitory effect of Secnidazole on bacteria of periodontitis and pericoronitis

In vivo inhibitory effect of Secnidazole on bacteria of periodontitis and pericoronitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003576
Enrollment
Unknown
Registered
2013-09-09
Start date
2013-09-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontitis and pericoronitis

Interventions

Group 1:periodontitis secnidazole
Group 2:periodontitis

Sponsors

Shanghai Ninth People’s Hospital affiliated to Shanghai Jiao Tong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. periodontitis Age 30-80 years; 2. The diagnosis is confirmed by Pericoronitis; 3. These patients had at least four teeth with pockets 5 mm and at least eight teeth with CAL3 mm.

Exclusion criteria

Exclusion criteria: Allergies to the antibiotics being used, antibiotic or periodontal treatment within the last 3 months, pregnancy, nursing, or systemic conditions that would influence the course of periodontal treatment, or allergy to AMOX, MET, TET, lidocaine, or chlorhex-idine. Both males and females of all races who were at least 20 years of age, had at least 15 natural teeth, and were in good general health were included in the study.

Design outcomes

Primary

MeasureTime frame
bacteria;

Countries

China

Contacts

Public ContactMingyu Li

Shanghai Research Institute of Stomatology, Ninth People’s Hospital, Medical College, Shanghai Jiao Tong University,

lmy1691@hotmail.com+86 13816949333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026